5-(3,5-Dimethyl-4-isoxazolyl)-1-[2-(4-morpholinyl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-1H-benzimidazole Hydrochloride is a potent and selective bromodomain of CREB binding protein (CBP BRD) inhibitor. 5-(3,5-Dimethyl-4-isoxazolyl)-1-[2-(4-morpholinyl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-1H-benzimidazole Hydrochloride downregulates inflammatory genes in macrophages and has therapeutic potential for treating neurological disorders.